Viewed as a series, or independently, the one-hour webinars will illustrate the multidisciplinary nature of disease management and the need for the incorporation of all treatment modalities to achieve optimal outcomes.
The series will highlight cutting-edge science from across the VCCC Alliance that could improve outcomes for this patient group.
Learn about what can be done in managing recurrent, residual or metastatic disease and the current and new approaches in palliative care.
Some of the leading researchers from across the VCCC Alliance will contribute to this session and share the latest advances relevant to tongue cancer. Hear about cutting-edge developments from Darido Charbel, Oliver Sieber, Paul Neeson, Lorraine O'Reilly, Michael McCullough and Tami Yap.
Program overview
Managing recurrent, residual or metastatic disease
Palliative care panel discussion with Brian Le
Future outlook
The series will conclude with a summary from Prof David Wiesenfeld.
The VCCC Alliance Research and Education Lead, Head and Neck Cancer program aims to map opportunities across the alliance to develop expert networks, deliver strategic educational programming, improve sharing of data for research, and implement multi-partner clinical trials to speed up the translation of new research into routine clinical practice.
